Published Date: 2022-04-28
Request a sample
European Oncology Market size is projected to reach USD 119.5 billion by 2028, according to a latest forecast report by Graphical Research.
Increasing number of cancer cases coupled with technological advancement in oncology treatment is expected to boost the market growth. Also, rising government initiatives to increase awareness for cancer diagnosis, treatment and care among the population is expected to boost the market growth. For instance, in 2021, the Europe Commission launched a Europe’s Beating Cancer Plan initiative that sets out a new Europe Union approach for cancer prevention and treatment through an integrated, health-in-all-policies and mutli-stakeholder approach. Thus, such initiatives by government and other organizations contributes in increasing awareness that will fuel the market size.
The cancer diagnostic segment held over 45.4% market share in 2021. Detecting cancer with an imaging test helps the healthcare professionals in deciding the course of treatment for the patient. With the increasing cancer prevalence, demand for imaging modalities is rapidly increasing in the European market. Also, to meet the growing demand, new technologies and techniques are commercialized by market players, intensifying the existing competition. Furthermore, technological advancements largely contribute to the market demand by boosting its adoption rates.
The prostate cancer type segment will surpass USD 12.1 billion revenue by 2028, attributed to sedentary lifestyle, unhealthy habits such as, smoking, tobacco consumption. Also, family history of prostate cancer, obesity and old age increases the risk of prostate cancer. Thus, increasing burden of prostate cancer along with availability of advance tools for diagnosis and treatment is expected to spur the industry size.
Browse detailed statistical insights from the report, “Europe Oncology Market Forecast 2028 By End-use (Hospitals, Diagnostic Laboratories, Diagnostic Imaging Centers, Academia, Specialty Clinics), By Cancer Diagnostics & Treatment (Cancer Diagnostics {Tumor Biomarkers Tests, Imaging, Biopsy, Liquid Biopsy, Immunohistochemistry, In Situ Hybridization}, Cancer Treatment {Chemotherapy, Targeted Therapy, Immunotherapy, Hormonal Therapy}), By Cancer Type (Lung Cancer, Prostate Cancer, Colon & Rectal Cancer, Gastric Cancer, Esophageal Cancer, Liver Cancer, Breast Cancer), Research Report, Country Outlook (Germany, UK, France, Spain, Italy, Switzerland, Netherlands, Belgium, Austria, Poland, Sweden, Norway), COVID-19 Impact Statistics, Price Trends, Historic Data, Growth Prospects, Competitive Industry Share” along with the table of contents (ToC) @
https://www.graphicalresearch.com/industry-insights/2105/europe-oncology-market
The diagnostic laboratories segment will grow at 8.5% CAGR during the forecast period owing to rising prevalence of cancer cases in the European region. Diagnostics laboratories offer lab tests, imagining scans and tumor biopsy among others. Similarly, the laboratories offer accurate testing and precise test results owing to availability of skilled technicians to perform lab tests.
France oncology market dominated around USD 12,595.3 million revenue in 2021. The cancer incidence rate in France has increased in past few years and it is the second leading cause for death in the country. This rising incidence in the country is attributable to sedentary lifestyle, smoking and tobacco consumption among others. Thus, growing prevalence of cancer in the country along with government initiatives to curb the disease is expected to foster the market size.
The oncology in European market research report includes in-depth coverage of the industry with estimates & forecast in terms of revenue in USD million from 2017 to 2028, for the following segments:
Europe Market, By Cancer Diagnostics & Treatment
Europe Market, By Cancer Type
Europe Market, By End-use
The above information has been provided for the following countries:
LSI keywords:
The great explorer of the truth, the master-builder of human happiness no one rejects dislikes avoids pleasure itself because it is pleasure but because know who do not those how to pursue pleasures rationally encounter consequences that are extremely painful desires to obtain.
Read More